SCHEMBL751369

SCHEMBL751369

COC(=O)NCC(C)CC(=O)N1CCCC1C(=O)Nc1ccc(CCc2ccc(NC(=O)C3CCCN3C(=O)C(NC(=O)OC)C(C)C)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.49
CYP3A4 P08684 6/20 0.45
CYP2C9 P11712 6/20 0.45
CYP2C19 P33261 5/20 0.45
CYP2D6 P10635 2/20 0.45
CYP1A2 P05177 3/20 0.44
ELANE P08246 7/20 0.43
CMA1 P23946 2/20 0.43
TAAR1 Q96RJ0 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL750422 0.91 KCNH2 (0.48) KCNH2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL749726 0.91 KCNH2 (0.48) KCNH2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL2707393 0.90 KCNH2 (0.58) KCNH2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL204846 0.90 KCNH2 (0.58) KCNH2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL18462724 0.90 KCNH2 (0.58) KCNH2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL13071007 0.85 KCNH2 (0.53) KCNH2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL13125139 0.82 KCNH2 (0.58) KCNH2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL17490819 0.81 KCNH2 (0.70) KCNH2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL18648212 0.81 KCNH2 (0.70) KCNH2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL17490823 0.81 KCNH2 (0.70) KCNH2CYP3A4CYP2C9CYP2C19CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2430014-A1 ANTIVIRAL COMPOUNDS Gilead Sciences, Inc. (US) 2012-03-21 EP disclosed
WO-2010132601-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. (US) 2010-11-18 WO disclosed